Search hospitals > New Jersey > Neptune
Jersey Shore University Medical Center
Claim this profileNeptune, New Jersey 07753
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Adenocarcinoma
Conducts research for Lung Cancer
Conducts research for Ovarian Cancer
184 reported clinical trials
18 medical researchers
Summary
Jersey Shore University Medical Center is a medical facility located in Neptune, New Jersey. This center is recognized for care of Cancer, Breast Cancer, Adenocarcinoma, Lung Cancer, Ovarian Cancer and other specialties. Jersey Shore University Medical Center is involved with conducting 184 clinical trials across 347 conditions. There are 18 research doctors associated with this hospital, such as Burton E. Appel, Andrew L. Pecora, Thomas L. Bauer, and Carlos Eduardo Silva Correia.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
ER positive
PR positive
Top PIs
Burton E. AppelHackensack University Medical Center4 years of reported clinical research
Studies Lymphoma
Studies Leukemia
23 reported clinical trials
60 drugs studied
Andrew L. PecoraHackensack University Medical Center1 year of reported clinical research
Studies Melanoma
Studies Skin Cancer
11 reported clinical trials
14 drugs studied
Thomas L. BauerOcean Medical Center9 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
9 reported clinical trials
15 drugs studied
Carlos Eduardo Silva CorreiaJersey Shore Medical Center2 years of reported clinical research
Studies Glioblastoma
Studies Brain Tumor
5 reported clinical trials
13 drugs studied
Clinical Trials running at Jersey Shore University Medical Center
Non-Small Cell Lung Cancer
Cutaneous Melanoma
Lung Cancer
Melanoma
Heart Failure
Liposarcoma
Mitral Valve Regurgitation
Skin Cancer
Pancreatic Cancer
Stroke
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This clinical trial plans to assess to what extent the on-treatment circulating tumor DNA (ctDNA) can predict the subset of patients with NSCLC who will respond to immunotherapy treatment only and which patients will need both immunotherapy and chemotherapy modalities for their treatment regimen.
Recruiting1 award Phase 219 criteria
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Jersey Shore University Medical Center?
Jersey Shore University Medical Center is a medical facility located in Neptune, New Jersey. This center is recognized for care of Cancer, Breast Cancer, Adenocarcinoma, Lung Cancer, Ovarian Cancer and other specialties. Jersey Shore University Medical Center is involved with conducting 184 clinical trials across 347 conditions. There are 18 research doctors associated with this hospital, such as Burton E. Appel, Andrew L. Pecora, Thomas L. Bauer, and Carlos Eduardo Silva Correia.